Dr. Yu is currently the Deputy Director of the Office of Pharmaceutical Quality (OPQ) in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). He directs over 1,300 staff involved in new, generic, and biotechnology drug product quality assessment and inspection functions, as well as the laboratories supporting pharmaceutical quality. He is also adjunct Professor of Pharmaceutical Engineering at the University of Michigan.
The Parenteral Drug Association (PDA) is the leading industry provider of science, technology and regulatory information. PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers education for the community. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical/ biopharmaceutical manufacturing science and regulation so members can better serve patients.